Arcinova - A Quotient Sciences Company | Arcinova Ltd. – Alnwick, UK
Arcinova - A Quotient Sciences Company | Arcinova Ltd. – Alnwick, UK
Verified Growth PartnerUnited KingdomFDF / DRUG PRODUCTSSERVICESCHEMICAL-SYNTHETIC
Arcinova accelerates drug development from early discovery to proof of concept and beyond.
About the Plant
Arcinova is a specialist contract research, development and manufacturing organisation supporting pharmaceutical and biotechnology companies from discovery through early clinical development. We provide expertise in drug substance development, aseptic drug product development and manufacture, bioanalysis and isotope labelling, helping customers generate the data, materials and insights needed to progress programmes with confidence. Our drug substance capabilities include medicinal chemistry, process chemistry, API development, process optimisation, route scouting, scale-up and GMP manufacture of active pharmaceutical ingredients. We support customers developing innovative therapies across a wide range of therapeutic areas, providing flexible solutions tailored to the needs of emerging biotech companies and established pharmaceutical organisations alike. Arcinova is also recognised for its expertise in radiochemistry and isotope labelling, supporting Human ADME studies through the synthesis of carbon-14 radiolabelled compounds. Combined with our bioanalytical capabilities, including metabolite identification, metabolite profiling, pharmacokinetic analysis and regulatory bioanalysis, we help clients generate critical data to support informed development decisions. Our aseptic drug product team provides development and manufacture of sterile dosage forms for early-phase clinical studies, supporting customers with formulation development, clinical trial materials and associated CMC activities. Regulatory and quality expertise are embedded throughout our services, helping programmes progress with confidence while meeting global regulatory expectations. As the specialist centre of excellence within Quotient Sciences, Arcinova can be engaged as a standalone partner or as part of a broader integrated development pathway that includes larger manufacturing capabilities and clinical pharmacology services. Whether supporting a single project requirement or delivering integrated programmes across multiple disciplines, Arcinova helps reduce development complexity, improve communication between project teams and accelerate the progression of new molecules. We combine scientific expertise, agility and collaborative project delivery to help pharmaceutical and biotechnology companies advance innovative medicines towards the clinic.